Table 3.

Association between myasthenia gravis and sick leave during 1 and 2-years follow up

	≥9 weeks, n (%)	Unadjusted OR (95% CI)	Adjusted OR (95% CI)a
Comparison groups	≥9 weeks sick leave, 1 year after diagnosis/match
MG vs. matched references	136 (41.2)/225 (3.4)	19.86 (15.37–25.67)	14.80 (10.97–19.95)
MG: age 40+ vs. 18–39	84 (42.9)/52 (38.8)	1.18 (0.76–1.85)	1.25 (0.70–2.24)
MG: male vs. female	50 (38.5)/86 (43.0)	0.83 (0.53–1.30)	0.66 (0.38–1.15)
MG: AChEI+ vs. AChEI	76 (44.2)/60 (38.0)	1.29 (0.83–2.01)	1.17 (0.70–1.96)
Comparison groups	≥9 weeks sick leave, 2 years after diagnosis/match
MG vs. matched references	155 (47.0)/448 (6.8)	12.16 (9.60–15.41)	8.60 (6.60–11.23)
MG: age 40+ vs. 18–39	94 (48.0)/61 (45.5)	1.10 (0.71–1.71)	1.34 (0.76–2.36)
MG: male vs. female	53 (40.8)/102 (51.0)	0.66 (0.42–1.0)	0.50 (0.29–0.86)
MG: AChEI+ vs. AChEI	91 (52.9)/64 (40.5)	1.65 (1.07–2.55)	1.61 (0.98–2.64)

Abbreviations: MG myasthenia gravis, AChEI Acetylcholinesterase inhibitors, AChEI+ AChEI + immunosuppression, OR odds ratio, CI confidence interval

^aAdjusted for age, gender, profession, marital status, pharmacological treatment, sick leave 1 year before diagnosis/match, and time period